News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Ipsen’s First Nine Months Of 2006 Sales
October 30, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS--(BUSINESS WIRE)--Ipsen (Paris:IPN), reported today its sales for the first nine months of 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
·
2 min read
·
Tristan Manalac
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
August 20, 2025
·
1 min read
·
Tristan Manalac
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
·
2 min read
·
Heather McKenzie
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
August 19, 2025
·
1 min read
·
Tristan Manalac
